Troponin elevation after percutaneous coronary intervention predicts major cardiac adverse outcomes in patients with non-ST-segment elevation acute coronary syndromes: Results from the SYNERGY trial

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY(2007)

引用 0|浏览18
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要